Cytori Therapeutics (CYTX) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Wall St futures rise ahead of jobs report as bond market steadies, oil slips
- U.S. economy adds 29,000 jobs in September
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- BofA's Hartnett sees risk-off mood lasting until dollar peaks
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Twilio, Vylor set to join S&P 500 as index reshuffles members
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
Cytori Therapeutics (CYTX) Files $40M Common Shelf
March 16, 2015 5:04 PM EDTCytori Therapeutics (NASDAQ: CYTX) filed to sell up to $40 million worth of its Common Stock.
... MoreCytori Therapeutics (CYTX) Regains Nasdaq Listing Compliance
March 12, 2015 2:42 PM EDTOn March 12, 2015, Cytori Therapeutics (NASDAQ: CYTX) received written notification from The NASDAQ Stock Market LLC (NASDAQ) that it has regained compliance with the Nasdaq Stock Market Listing Rule 5450(a)(1) concerning the Companys closing bid price. The Company previously received written notification from NASDAQ indicating... More
